Mealey's Antitrust/Unfair Competition - Judge Compels UCL, Fraud Claim Against Pharma Company To Arbitration In Hong Kong

Mealey's Antitrust/Unfair Competition - Judge Compels UCL, Fraud Claim Against Pharma Company To Arbitration In Hong Kong

SAN DIEGO - After finding that a California natural plant company's claims for violation of California's unfair competition law (UCL) and fraud against a group of companies and their officer in relation to a distribution agreement arose directly under an underlying contract, a California federal judge on Jan. 8 compelled the claims against one business entity to arbitration in Hong Kong (Everest Biosynthesis Group LLC, dba Natural Plant Extracts v. Biosynthesis Pharma Group Limited, et al., No. 17cv1466, S.D. Calif., 2018 U.S. Dist. LEXIS 3258).

Find full version on lexis Advance®